Managing Methylation

A long noncoding RNA associated with DNA methylation has the power to regulate colon cancer growth in vitro.

Written byKaren Zusi
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

UNSUPERVISED: In a healthy colon cell, the DNA methyltransferase DNMT1 interacts with the long noncoding RNA DACOR1 to properly methylate the cell’s genomic material (1). DACOR1 is downregulated in cancer cells, thus upsetting DNMT1’s activity and changing the cells’ methylation patterns to promote tumor growth (2). Adding DACOR1 back into cancer cells restores some normal methylation and gene expression (3).© LUCY READING-IKKANDA

The paper
C.R. Merry et al., “DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer,” Hum Mol Genet, 24:6240-53, 2015.

DNA methylation is a critical regulator of gene activity. In cancer cells, faulty methylation patterns contribute to the excessive growth and dysfunction characteristic of tumors. While increased methylation often occurs at sites of tumor suppressor genes—turning off their activity—reduced methylation is widespread throughout other parts of the genome, freeing up many sections of DNA to be improperly expressed.

“No one understands what’s driving the hypomethylation” in cancer cells, says Ahmad Khalil, a geneticist at Case Western Reserve University in Ohio. “The initial hypothesis was that maybe the enzymes regulating histone modification or DNA methylation are mutated, or their expression is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies